Jesús Ontañón

942 total citations
54 papers, 595 citations indexed

About

Jesús Ontañón is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Jesús Ontañón has authored 54 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Jesús Ontañón's work include Immune Cell Function and Interaction (35 papers), T-cell and B-cell Immunology (34 papers) and Immunotherapy and Immune Responses (19 papers). Jesús Ontañón is often cited by papers focused on Immune Cell Function and Interaction (35 papers), T-cell and B-cell Immunology (34 papers) and Immunotherapy and Immune Responses (19 papers). Jesús Ontañón collaborates with scholars based in Spain and United States. Jesús Ontañón's co-authors include Dolores C. Garcı́a-Olmo, Damián García‐Olmo, Luis Marı́n, Mario Vallejo, Julio Escribano, Emili Martı́nez, J.A. Fernández, Esperanza Martı́nez-Romero, Alfredo Minguela and Alberto Torı́o and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jesús Ontañón

50 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesús Ontañón Spain 12 207 190 165 103 94 54 595
Yan Tang China 14 219 1.1× 167 0.9× 311 1.9× 75 0.7× 49 0.5× 25 642
Seiko Kato Japan 14 127 0.6× 99 0.5× 142 0.9× 45 0.4× 68 0.7× 80 691
Ikuya Fujiwara Japan 14 102 0.5× 229 1.2× 150 0.9× 127 1.2× 148 1.6× 43 648
Dingming Wan China 14 133 0.6× 225 1.2× 120 0.7× 102 1.0× 15 0.2× 56 563
Ingrid Jurickova United States 13 137 0.7× 212 1.1× 373 2.3× 48 0.5× 105 1.1× 30 757
William S. Bowen United States 10 79 0.4× 159 0.8× 220 1.3× 22 0.2× 141 1.5× 17 578
AW Lohse Germany 11 78 0.4× 103 0.5× 301 1.8× 23 0.2× 124 1.3× 70 859
Karen S. Keslar United States 13 153 0.7× 190 1.0× 211 1.3× 25 0.2× 111 1.2× 25 591
Virginia Belsúe Spain 8 300 1.4× 108 0.6× 278 1.7× 30 0.3× 61 0.6× 16 577
Cathleen J. Ciesielski United Kingdom 8 139 0.7× 143 0.8× 278 1.7× 103 1.0× 22 0.2× 11 540

Countries citing papers authored by Jesús Ontañón

Since Specialization
Citations

This map shows the geographic impact of Jesús Ontañón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Ontañón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Ontañón more than expected).

Fields of papers citing papers by Jesús Ontañón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Ontañón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Ontañón. The network helps show where Jesús Ontañón may publish in the future.

Co-authorship network of co-authors of Jesús Ontañón

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Ontañón. A scholar is included among the top collaborators of Jesús Ontañón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Ontañón. Jesús Ontañón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marı́n, Luis & Jesús Ontañón. (2025). Two New Alleles, HLA ‐B*40:06:01:20 and HLADRB1 *09: 61N , Detected in a Spanish Bone Marrow Donor. HLA. 105(5). e70227–e70227.
2.
Marı́n, Luis & Jesús Ontañón. (2025). HLADRB1*08:130 Is the First DRB1 Allele Described With a Leucine at Position 64 of Beta‐1 Domain. HLA. 105(1). e70016–e70016. 1 indexed citations
3.
Cimas, Francisco J., Jesús Ontañón, Fernando Andrés‐Pretel, et al.. (2025). Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production. Frontiers in Immunology. 15. 1471401–1471401. 1 indexed citations
4.
Marı́n, Luis & Jesús Ontañón. (2025). Six New Intronic Variants of HLA‐A Detected by Next‐Generation Sequencing. HLA. 105(3). e70144–e70144. 1 indexed citations
5.
Marı́n, Luis & Jesús Ontañón. (2025). HLA‐DPA1*01:228 is the First DPA1 Allele Described With an Alanine at Position 42 of Alpha‐1 Domain. HLA. 106(5). e70450–e70450.
6.
Marı́n, Luis & Jesús Ontañón. (2024). Characterisation of five new variants of HLADPA1. HLA. 103(6). 2 indexed citations
7.
Marı́n, Luis & Jesús Ontañón. (2024). HLA‐DQA1*05:115, the first DQA1 allele described with an alanine at position 59 of alpha‐1 domain. HLA. 104(3). e15695–e15695. 2 indexed citations
8.
Marı́n, Luis & Jesús Ontañón. (2023). Identification of three novel HLA class I alleles: HLA‐B*15:640, ‐B*18:01:01:71 and ‐C*05:275. HLA. 102(1). 77–78. 1 indexed citations
9.
Marı́n, Luis & Jesús Ontañón. (2023). Three novel variants of HLA‐DQB1*06 identified by next‐generation sequencing. HLA. 103(1). e15315–e15315. 2 indexed citations
10.
Marı́n, Luis & Jesús Ontañón. (2023). Identification of four novel HLA‐DQA1 alleles: HLA‐DQA1*01:01:02:04, 01:04:01:05, 03:03:01:19 and 05:01:01:08. HLA. 102(3). 378–379. 2 indexed citations
11.
Torı́o, Alberto, et al.. (2018). Anti-HLA Antibodies After Precocious Transplantectomy by Vascular Thrombosis. Transplantation Proceedings. 50(2). 546–549.
12.
Aroca‐Aguilar, José‐Daniel, et al.. (2018). Identification of myocilin as a blood plasma protein and analysis of its role in leukocyte adhesion to endothelial cell monolayers. PLoS ONE. 13(12). e0209364–e0209364. 5 indexed citations
13.
Asensio, Esther, Marcos López‐Hoyos, Íñigo Romón, Jesús Ontañón, & David San Segundo. (2017). Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness. Frontiers in Immunology. 8. 540–540. 6 indexed citations
14.
Lucendo, Alfredo J., Ángel Arias, Isabel Pérez‐Martínez, et al.. (2010). Adult Patients with Eosinophilic Esophagitis Do Not Show an Increased Frequency of the HLA-DQ2/DQ8 Genotypes Predisposing to Celiac Disease. Digestive Diseases and Sciences. 56(4). 1107–1111. 24 indexed citations
15.
Garcı́a-Olmo, Dolores C., et al.. (1999). Effects of Long-Term Treatment of Colon Adenocarcinoma With Crocin, a Carotenoid From Saffron (Crocus sativus L.): An Experimental Study in the Rat. Nutrition and Cancer. 35(2). 120–126. 122 indexed citations
16.
García‐Olmo, Damián, et al.. (1999). Experimental evidence does not support use of the “no-touch” isolation technique in colorectal cancer. Diseases of the Colon & Rectum. 42(11). 1449–1454. 20 indexed citations
17.
Minguela, Alfredo, Luis Marı́n, Alberto Torı́o, et al.. (1999). CD30+ and CD27− lymphocytes in liver transplant: Th2 cytokine secretion. Transplantation Proceedings. 31(1-2). 516–518. 6 indexed citations
18.
Escribano, Julio, María José Guerra Palmero, Hans H. Riese, et al.. (1999). In vitro activation of macrophages by a novel proteoglycan isolated from corms of Crocus sativus L. Cancer Letters. 144(1). 107–114. 26 indexed citations
19.
Muro, Manuel, Luis Marı́n, Alberto Torı́o, et al.. (1999). Effect of HLA matching on liver graft survival. Transplantation Proceedings. 31(6). 2477–2479. 10 indexed citations
20.
Minguela, Alfredo, Alberto Torı́o, Luis Marı́n, et al.. (1999). Implication of Th1, Th2, and Th3 cytokines in liver graft acceptance. Transplantation Proceedings. 31(1-2). 519–520. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026